Update on radiologic evaluation of common malignancies:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Elsevier Saunders
2007
|
| Schriftenreihe: | Radiologic clinics of North America
45,1 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XII, 230 S. zahlr. Ill., graph. Darst. |
| ISBN: | 1416047883 9781416047889 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV022239471 | ||
| 003 | DE-604 | ||
| 005 | 20100211 | ||
| 007 | t | ||
| 008 | 070124s2007 ad|| |||| 00||| eng d | ||
| 020 | |a 1416047883 |9 1-4160-4788-3 | ||
| 020 | |a 9781416047889 |9 978-1-4160-4788-9 | ||
| 035 | |a (OCoLC)78051876 | ||
| 035 | |a (DE-599)BVBBV022239471 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RC270.3.D53 | |
| 245 | 1 | 0 | |a Update on radiologic evaluation of common malignancies |c guest ed. Hedvig Hricak ... |
| 264 | 1 | |a Philadelphia [u.a.] |b Elsevier Saunders |c 2007 | |
| 300 | |a XII, 230 S. |b zahlr. Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Radiologic clinics of North America |v 45,1 | |
| 650 | 7 | |a Radiologie |2 gtt | |
| 650 | 7 | |a Tumoren |2 gtt | |
| 650 | 4 | |a Cancer |x Diagnosis | |
| 650 | 4 | |a Cancer |x Imaging | |
| 650 | 4 | |a Cancer |x Interventional radiology | |
| 650 | 4 | |a Diagnostic imaging | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 4 | |a Technology, Radiologic | |
| 700 | 1 | |a Hricak, Hedvig |e Sonstige |0 (DE-588)136692990 |4 oth | |
| 830 | 0 | |a Radiologic clinics of North America |v 45,1 |w (DE-604)BV000003369 |9 45,1 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015450418&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-015450418 | ||
Datensatz im Suchindex
| _version_ | 1804136230608175104 |
|---|---|
| adam_text | Contents
Preface xi
Hedvig Hricak and David M. Panicek
Oral Cavity and Oropharynx Tumors 1
Hilda E. Stambuk, Sasan Karimi, Nancy Lee, and Snehal G. Patel
Cancers of the oral cavity and pharynx are the most common head and neck cancers in
the United States, and squamous cell carcinoma is the most frequent histologic type. The
clinical behavior and outcome of tumors in the oral cavity is distinct from those of the
oropharynx. As a general rule, surgical resection is the primary treatment for oral cavity
squamous cell carcinoma, whereas oropharyngeal squamous cell carcinomas are treated
with radiation with or without chemotherapy. A clear understanding of the anatomy
and knowledge of the clinical behavior and spread patterns of oral cavity and
oropharyngeal squamous cell carcinoma are essential for radiologists to make
a meaningful contribution to the treatment of these patients.
Lung Cancer 21
Michelle S. Ginsberg, Ravinder K. Grewal, and Robert T. Heelan
Lung cancer is the most frequently occurring cancer in the world, and in the United
States it is the second most common cancer diagnosed. Accurate staging by imaging can
have a significant impact on appropriate treatment and surgical options. Familiarity
with the different histologic subtypes of lung cancer and the typical and atypical
appearances of lung cancer is vital. Radiologists serve a critical role in the diagnosis,
staging, and follow up of patients with lung cancer.
Imaging Breast Cancer 45
Lia Bartella, Clare S. Smith, D. David Dershaw, and Laura Liberman
Imaging has a significant role in diagnosing, treating, and monitoring breast cancer.
Advances in this field are having a great impact in the clinical management of this
disease. Breast cancer has now become an outpatient cancer. This article describes the
role and advances of imaging in breast cancer.
Hodgkin s and Non Hodgkin s Lymphomas 69
Jurgen Rademaker
The diagnosis and management of lymphoma have undergone significant changes in
the past 20 years. For example, new immunophenotypic and molecular methods have
replaced traditional histology based classification schemes for lymphoma. Fluorine 18
deoxyglucose (FDG) positron emission tomography (PET) has evolved into a potent
staging tool and prognostic indicator in many kinds of lymphoma. The role of radiation
therapy, especially in patients who have early stage Hodgkin s disease, has changed
substantially. The introduction of anti CD 20 antibody therapy (Rituximab) has
improved the treatment of B cell lymphoma. These changes are linked with higher
expectations for imaging, such as detection of more subtle lymphoma manifestations,
evaluation of residual changes, and better assessment of early response. This article
reviews clinical and radiologic features of both Hodgkin s disease and non Hodgkin s
lymphoma. It also describes the radiologic staging of lymphoma and the emerging role
of FDG PET for assessing lymphoma.
Update on Colorectal Cancer Imaging 85
Marc J. Gollub, Lawrence H. Schwartz, and Timothy Akhurst
Colorectal cancer remains a leading cancer killer worldwide. The disease is both curable
and preventable, and yet the importance of widespread screening is only now starting to
be appreciated. This article reviews the variety of diagnostic tests, imaging procedures,
and endoscopic examinations available to detect colorectal cancer and polyps in their
early stage and also presents details on various screening options. The critical role of the
radiologist is elaborated on including accurate assessment of tumor extent within the
bowel wall and beyond and the detection of lymph node and distant metastases. Staging
with CT, MR imaging, endorectal ultrasound, and positron emission tomography are of
paramount importance in determining the most appropriate therapy and the risk of
tumor recurrence and overall prognosis.
Imaging of Kidney Cancer 119
Jingbo Zhang, Robert A. Lefkowitz, and Ariadne Bach
Advances in molecular genetics have expanded the understanding of renal cell tumors,
Now it is understood that renal cortical tumors are a family of neoplasms with distinct
cytogenetics and molecular defects, unique histopathologic features, and different
malignant potentials. Imaging contributes to clinical management of patients with renal
tumors in providing diagnostic information for tumor detection, characterization,
staging, treatment planning, and follow up.
Ovarian Cancer 149
Svetlana Mironov, Oguz Akin, Neeta Pandit Taskar, and Lucy Hann
Imaging has become an essential part of the clinical management of patients with
ovarian cancer, contributing to tumor detection, characterization, staging, treatment
planning, and follow up. Imaging findings incorporated into the clinical impression
assist in creating a treatment plan specific for an individual patient. Advances in cross
sectional imaging and nuclear medicine (PET) have yielded new insights into the
evaluation of tumor prognostic factors. A multimodality approach can satisfy the
complex imaging needs of a patient with ovarian cancer; however, the success of such an
approach always depends on available resources and on the skills of the physicians
involved.
Imaging of Uterine Cancer 167
Oguz Akin, Svetlana Mironov, Neeta Pandit Taskar, and Lucy E. Hann
Although surgical staging is the primary method of assessing prognostic factors in
endometrial cancer, cross sectional imaging may help in treatment planning by
providing information about factors such as the depth of myometrial invasion, cervical
involvement, and nodal status. The pretreatment evaluation of cervical cancer
traditionally has consisted of clinical evaluation, laboratory tests, and conventional
radiographic studies, but more advanced imaging methods allow additional insights
into the morphologic and metabolic features of cervical cancer. This article reviews the
applications of modern imaging modalities in the assessment of endometrial cancer and
cervical cancer and their impact on treatment planning and posttreatment follow up.
Imaging of Bladder Cancer 183
Jingbo Zhang, Scott Cerst, Robert A. Lefkowitz, and Ariadne Bach
Bladder cancer is a heterogeneous and frequently multifocal disease with a variable
clinical course. The management of bladder cancer is therefore challenging and
complicated. CTand MR imaging have replaced the traditional excretory urography and
are emerging as the imaging modalities of choice for work up of patients who have
bladder cancer. Imaging provides essential diagnostic information for detection, staging,
and post treatment follow up of bladder cancer.
Imaging of Prostate Cancer 207
Oguz Akin and Hedvig Hricak
The role of imaging in the diagnosis and management of prostate cancer is reviewed.
Transrectal ultrasonography, which can be used to guide biopsy, is the most frequently
used imaging technique in cancer detection. For determining the extent of disease, CT
and MR imaging are the most commonly used modalities; bone scintigraphy and
positron emission tomography have roles only in advanced disease. Currently, the role
of imaging in prostate cancer is evolving to improve disease detection and staging, to
determine the aggressiveness of disease, and to predict outcomes in different patient
populations.
Index 223
|
| adam_txt |
Contents
Preface xi
Hedvig Hricak and David M. Panicek
Oral Cavity and Oropharynx Tumors 1
Hilda E. Stambuk, Sasan Karimi, Nancy Lee, and Snehal G. Patel
Cancers of the oral cavity and pharynx are the most common head and neck cancers in
the United States, and squamous cell carcinoma is the most frequent histologic type. The
clinical behavior and outcome of tumors in the oral cavity is distinct from those of the
oropharynx. As a general rule, surgical resection is the primary treatment for oral cavity
squamous cell carcinoma, whereas oropharyngeal squamous cell carcinomas are treated
with radiation with or without chemotherapy. A clear understanding of the anatomy
and knowledge of the clinical behavior and spread patterns of oral cavity and
oropharyngeal squamous cell carcinoma are essential for radiologists to make
a meaningful contribution to the treatment of these patients.
Lung Cancer 21
Michelle S. Ginsberg, Ravinder K. Grewal, and Robert T. Heelan
Lung cancer is the most frequently occurring cancer in the world, and in the United
States it is the second most common cancer diagnosed. Accurate staging by imaging can
have a significant impact on appropriate treatment and surgical options. Familiarity
with the different histologic subtypes of lung cancer and the typical and atypical
appearances of lung cancer is vital. Radiologists serve a critical role in the diagnosis,
staging, and follow up of patients with lung cancer.
Imaging Breast Cancer 45
Lia Bartella, Clare S. Smith, D. David Dershaw, and Laura Liberman
Imaging has a significant role in diagnosing, treating, and monitoring breast cancer.
Advances in this field are having a great impact in the clinical management of this
disease. Breast cancer has now become an "outpatient cancer." This article describes the
role and advances of imaging in breast cancer.
Hodgkin's and Non Hodgkin's Lymphomas 69
Jurgen Rademaker
The diagnosis and management of lymphoma have undergone significant changes in
the past 20 years. For example, new immunophenotypic and molecular methods have
replaced traditional histology based classification schemes for lymphoma. Fluorine 18
deoxyglucose (FDG) positron emission tomography (PET) has evolved into a potent
staging tool and prognostic indicator in many kinds of lymphoma. The role of radiation
therapy, especially in patients who have early stage Hodgkin's disease, has changed
substantially. The introduction of anti CD 20 antibody therapy (Rituximab) has
improved the treatment of B cell lymphoma. These changes are linked with higher
expectations for imaging, such as detection of more subtle lymphoma manifestations,
evaluation of residual changes, and better assessment of early response. This article
reviews clinical and radiologic features of both Hodgkin's disease and non Hodgkin's
lymphoma. It also describes the radiologic staging of lymphoma and the emerging role
of FDG PET for assessing lymphoma.
Update on Colorectal Cancer Imaging 85
Marc J. Gollub, Lawrence H. Schwartz, and Timothy Akhurst
Colorectal cancer remains a leading cancer killer worldwide. The disease is both curable
and preventable, and yet the importance of widespread screening is only now starting to
be appreciated. This article reviews the variety of diagnostic tests, imaging procedures,
and endoscopic examinations available to detect colorectal cancer and polyps in their
early stage and also presents details on various screening options. The critical role of the
radiologist is elaborated on including accurate assessment of tumor extent within the
bowel wall and beyond and the detection of lymph node and distant metastases. Staging
with CT, MR imaging, endorectal ultrasound, and positron emission tomography are of
paramount importance in determining the most appropriate therapy and the risk of
tumor recurrence and overall prognosis.
Imaging of Kidney Cancer 119
Jingbo Zhang, Robert A. Lefkowitz, and Ariadne Bach
Advances in molecular genetics have expanded the understanding of renal cell tumors,
Now it is understood that renal cortical tumors are a family of neoplasms with distinct
cytogenetics and molecular defects, unique histopathologic features, and different
malignant potentials. Imaging contributes to clinical management of patients with renal
tumors in providing diagnostic information for tumor detection, characterization,
staging, treatment planning, and follow up.
Ovarian Cancer 149
Svetlana Mironov, Oguz Akin, Neeta Pandit Taskar, and Lucy Hann
Imaging has become an essential part of the clinical management of patients with
ovarian cancer, contributing to tumor detection, characterization, staging, treatment
planning, and follow up. Imaging findings incorporated into the clinical impression
assist in creating a treatment plan specific for an individual patient. Advances in cross
sectional imaging and nuclear medicine (PET) have yielded new insights into the
evaluation of tumor prognostic factors. A multimodality approach can satisfy the
complex imaging needs of a patient with ovarian cancer; however, the success of such an
approach always depends on available resources and on the skills of the physicians
involved.
Imaging of Uterine Cancer 167
Oguz Akin, Svetlana Mironov, Neeta Pandit Taskar, and Lucy E. Hann
Although surgical staging is the primary method of assessing prognostic factors in
endometrial cancer, cross sectional imaging may help in treatment planning by
providing information about factors such as the depth of myometrial invasion, cervical
involvement, and nodal status. The pretreatment evaluation of cervical cancer
traditionally has consisted of clinical evaluation, laboratory tests, and conventional
radiographic studies, but more advanced imaging methods allow additional insights
into the morphologic and metabolic features of cervical cancer. This article reviews the
applications of modern imaging modalities in the assessment of endometrial cancer and
cervical cancer and their impact on treatment planning and posttreatment follow up.
Imaging of Bladder Cancer 183
Jingbo Zhang, Scott Cerst, Robert A. Lefkowitz, and Ariadne Bach
Bladder cancer is a heterogeneous and frequently multifocal disease with a variable
clinical course. The management of bladder cancer is therefore challenging and
complicated. CTand MR imaging have replaced the traditional excretory urography and
are emerging as the imaging modalities of choice for work up of patients who have
bladder cancer. Imaging provides essential diagnostic information for detection, staging,
and post treatment follow up of bladder cancer.
Imaging of Prostate Cancer 207
Oguz Akin and Hedvig Hricak
The role of imaging in the diagnosis and management of prostate cancer is reviewed.
Transrectal ultrasonography, which can be used to guide biopsy, is the most frequently
used imaging technique in cancer detection. For determining the extent of disease, CT
and MR imaging are the most commonly used modalities; bone scintigraphy and
positron emission tomography have roles only in advanced disease. Currently, the role
of imaging in prostate cancer is evolving to improve disease detection and staging, to
determine the aggressiveness of disease, and to predict outcomes in different patient
populations.
Index 223 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_GND | (DE-588)136692990 |
| building | Verbundindex |
| bvnumber | BV022239471 |
| callnumber-first | R - Medicine |
| callnumber-label | RC270 |
| callnumber-raw | RC270.3.D53 |
| callnumber-search | RC270.3.D53 |
| callnumber-sort | RC 3270.3 D53 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)78051876 (DE-599)BVBBV022239471 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01531nam a2200409 cb4500</leader><controlfield tag="001">BV022239471</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100211 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070124s2007 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1416047883</subfield><subfield code="9">1-4160-4788-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781416047889</subfield><subfield code="9">978-1-4160-4788-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)78051876</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV022239471</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC270.3.D53</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Update on radiologic evaluation of common malignancies</subfield><subfield code="c">guest ed. Hedvig Hricak ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Elsevier Saunders</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 230 S.</subfield><subfield code="b">zahlr. Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Radiologic clinics of North America</subfield><subfield code="v">45,1</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumoren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Imaging</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Interventional radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic imaging</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Radiologic</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hricak, Hedvig</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)136692990</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Radiologic clinics of North America</subfield><subfield code="v">45,1</subfield><subfield code="w">(DE-604)BV000003369</subfield><subfield code="9">45,1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015450418&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015450418</subfield></datafield></record></collection> |
| id | DE-604.BV022239471 |
| illustrated | Illustrated |
| index_date | 2024-07-02T16:35:28Z |
| indexdate | 2024-07-09T20:53:06Z |
| institution | BVB |
| isbn | 1416047883 9781416047889 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-015450418 |
| oclc_num | 78051876 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | XII, 230 S. zahlr. Ill., graph. Darst. |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Elsevier Saunders |
| record_format | marc |
| series | Radiologic clinics of North America |
| series2 | Radiologic clinics of North America |
| spelling | Update on radiologic evaluation of common malignancies guest ed. Hedvig Hricak ... Philadelphia [u.a.] Elsevier Saunders 2007 XII, 230 S. zahlr. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Radiologic clinics of North America 45,1 Radiologie gtt Tumoren gtt Cancer Diagnosis Cancer Imaging Cancer Interventional radiology Diagnostic imaging Neoplasms therapy Technology, Radiologic Hricak, Hedvig Sonstige (DE-588)136692990 oth Radiologic clinics of North America 45,1 (DE-604)BV000003369 45,1 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015450418&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Update on radiologic evaluation of common malignancies Radiologic clinics of North America Radiologie gtt Tumoren gtt Cancer Diagnosis Cancer Imaging Cancer Interventional radiology Diagnostic imaging Neoplasms therapy Technology, Radiologic |
| title | Update on radiologic evaluation of common malignancies |
| title_auth | Update on radiologic evaluation of common malignancies |
| title_exact_search | Update on radiologic evaluation of common malignancies |
| title_exact_search_txtP | Update on radiologic evaluation of common malignancies |
| title_full | Update on radiologic evaluation of common malignancies guest ed. Hedvig Hricak ... |
| title_fullStr | Update on radiologic evaluation of common malignancies guest ed. Hedvig Hricak ... |
| title_full_unstemmed | Update on radiologic evaluation of common malignancies guest ed. Hedvig Hricak ... |
| title_short | Update on radiologic evaluation of common malignancies |
| title_sort | update on radiologic evaluation of common malignancies |
| topic | Radiologie gtt Tumoren gtt Cancer Diagnosis Cancer Imaging Cancer Interventional radiology Diagnostic imaging Neoplasms therapy Technology, Radiologic |
| topic_facet | Radiologie Tumoren Cancer Diagnosis Cancer Imaging Cancer Interventional radiology Diagnostic imaging Neoplasms therapy Technology, Radiologic |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015450418&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000003369 |
| work_keys_str_mv | AT hricakhedvig updateonradiologicevaluationofcommonmalignancies |